ADAP — Adaptimmune Therapeutics Adr Institutional Holders · Q1 2026
Who owns Adaptimmune Therapeutics Adr (ADAP)? 11 institutions reported holding $72 in SEC 13F filings for Q1 2026 (period ended 2026-03-31). Largest holders: Rhumbline Advisers ($72), Rathbones Group PLC ($0), Simplex Trading, LLC ($0).
| Rank | Institution | Value | Shares | Change |
|---|---|---|---|---|
| 1 | RHUMBLINE ADVISERS | $72 | 3,661 | Hold |
| 2 | Rathbones Group PLC | $0 | 0 | Exited |
| 3 | SIMPLEX TRADING, LLC | $0 | 0 | Exited |
| 4 | Empirical Finance, LLC | $0 | 0 | Exited |
| 5 | X-Square Capital, LLC | $0 | 0 | Exited |
| 6 | XTX Topco Ltd | $0 | 0 | Exited |
| 7 | JOSH ARNOLD INVESTMENT CONSULTANT, LLC | $0 | 0 | Exited |
| 8 | TD Waterhouse Canada Inc. | $0 | 0 | Exited |
| 9 | Raiffeisen Bank International AG | $0 | 0 | Exited |
| 10 | BARCLAYS PLC | $0 | 0 | Exited |
| 11 | ACADIAN ASSET MANAGEMENT LLC | $0 | 0 | Exited |
Source: SEC Form 13F filings · as of 2026-03-31